査読有
doi：10.1111/jgh.17024
PubMed No.：40448543
2023 Impact Factor：3.7
種類：原著
誌名：Journal of Gastroenterology and Hepatology
発行年月：2025年5月
巻号頁：in press
論題：Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria
著者：Takashi Niizeki, Seiichi Mawatari, Michihiko Shibata, Ryu Sasaki, Shinji Itoh, Satoshi Shakado, Rie Sugimoto, Yusuke Morita, Takuya Kuwashiro, Mizuki Endo, Masao Iwao, Yasuhide Motoyoshi, Masahito Nakano, Shigeo Shimose, Hirokazu Takahashi, Hiroshi Yatsuhashi, Fumihito Hirai, Tomoharu Yoshizumi, Hisamitsu Miyaaki, Takumi Kawaguchi, Akio Ido, Masaru Harada
